Examples:
Effect: decrease BP (vasodilation), decrease BV by decreasing sodium re-absorption in the kidney (no aldosterone)
Conditions:
Less preferred compared to ACEi(-pril) → the 2 should NOT be combined
CI:
MOA: block type 1 Angiotensin II receptor → prevent vasoconstriction & aldosterone production